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Abstract: Inflammatory bowel diseases (IBD) are debilitating chronic inflammatory disorders
that develop as a result of a defective immune response toward intestinal bacteria. Intestinal
dysbiosis is associated with the onset of IBD and has been reported to persist even in patients
in deep remission. We investigated the possibility of a dietary-induced switch to the gut microbiota
composition using Winnie mice as a model of spontaneous ulcerative colitis and chow enriched with
1% Bronze tomato. We used the near isogenic tomato line strategy to investigate the effects of a
diet enriched in polyphenols administered to mild but established chronic intestinal inflammation.
The Bronze-enriched chow administered for two weeks was not able to produce any macroscopic
effect on the IBD symptoms, although, at molecular level there was a significant induction of
anti-inflammatory genes and intracellular staining of T cells revealed a mild decrease in IL17A and
IFNγ production. Analysis of the microbial composition revealed that two weeks of Bronze enriched
diet was sufficient to perturb the microbial composition of Winnie and control mice, suggesting
that polyphenol-enriched diets may create unfavorable conditions for distinct bacterial species.
In conclusion, dietary regimes enriched in polyphenols may efficiently support IBD remission
affecting the intestinal dysbiosis.
Keywords: microbiota; inflammatory bowel disease (IBD); polyphenols; bronze tomatoes;
murine models
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1. Introduction
The link between the intestinal microbiota and intestinal chronic inflammatory syndromes has
been increasingly investigated over the past 20 years. Alterations in the composition of gastrointestinal
microbiota (gut dysbiosis) have been associated with numerous conditions, including metabolic disease
and inflammatory bowel disease (IBD) [1,2].
Due to the crucial involvement of the microbiota in onset of IBD, strategies targeting
IBD-associated intestinal dysbiosis are considered among the most promising therapies for future
treatment of IBD patients [3,4]. IBDs include two major disorders: ulcerative colitis (UC) and Crohn’s
disease (CD), both characterized by chronic intestinal inflammation and relapsing clinical courses,
but with distinct anatomic localization and inflammatory mediator profiles [1,2]. The triggers of IBDs
are as yet unknown, however, it is likely the origins are multifactorial resulting from a combination of
different factors that include genetic predisposition (such as NOD2 mutations) [5–8] and environmental
components such as childhood exposure to antibiotics [9–11] and diet [12–15]. These components
seem to perturb the composition of the intestinal microbiota promoting a switch from the “healthy”
microbiota to the “pathological” condition of dysbiosis [16–18].
We recently investigated the protective effects mediated by the administration of a diet enriched
with a tomato line called Bronze [19]. This near isogenic tomato line is enriched in several different
polyphenols and proved to be a powerful and innovative tool to evaluate the effects of plant bioactive
compounds, particularly in the context of the intestinal immune response in IBD [19]. We demonstrated
that the administration of a nutritional regime enriched with 1% of Bronze tomato fruit was able to
promote a change in the composition of the microbiota in healthy mice and partially suppress the
host inflammatory response to reduce/delay the appearance of intestinal damage induced by DSS
administration [19].
In contrast to the previous experimental setup, we built on our published findings and used a
murine model of spontaneous UC, Winnie, to investigate the therapeutic rather than the preventive
potential of the Bronze-enriched diet. Winnie mice are characterized by a point mutation in the
Muc2 gene that induces endoplasmic reticulum stress, intestinal barrier dysfunction and ultimately
an UC-like disease. Winnie mice develop chronologically progressive IBD symptoms resembling
human UC [20], including erosion of intestinal epithelium, increased intestinal cellularity, neutrophil
recruitment and appendiceal microbiome dysbiosis. Our aim was to determine the therapeutic
potential of a dietary intervention based on the Bronze-enriched diet in adult Winnie mice.
Our results indicate that, despite undetectable morphological improvement, two weeks of
Bronze-enriched diet was able to elicit the expression of several anti-inflammatory related genes
both in Wild type (WT) and Winnie mice. Furthermore, the bronze-enriched diet significantly impacted
the intestinal microbiome of both WT and Winnie mice.
2. Materials and Methods
2.1. Ethics Statement
Our investigations were conducted in accordance with national and international guidelines and
were approved by the authors’ institutional review board (Organism For Animal Wellbeing—OPBA).
All animal experiments were carried out in accordance with Directive 86/609 EEC enforced by Italian
D.L. n. 116/1992, and approved by the Committee on the Ethics of Animal Experiments of Ministero
della Salute–Direzione Generale Sanità Animale (Prot. 768/2015-PR 27/07/2015) and the official
RBM veterinarian. Animals were sacrificed if found to be in a severe clinical condition, to avoid
undue suffering.
2.2. Generation of Tomato Lines and Diets
The Bronze tomato line (E8:MYB12, E8:Del/Ros, 35S:StSy) was developed as previously
described [19].
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2.3. Murine Models
Sex- and weight-matched mice were divided into four groups (four mice each). WT mice were
purchased from Jackson Laboratories: (C57BL/6, Stock No. 000664), while Winnie mice were obtained
from the University of Tasmania.
Mice, pellet consumption and drinking water were monitored on a daily basis. Each group of mice
received a different diet. Freeze-dried tomato was supplemented by addition to a standard rodent diet
(4RF18) at 1% (tomato based-diets). Groups of mice were fed with the different tomato supplemented
diets for two weeks. Body weight, stool consistency and rectal bleeding were recorded. Mice were
sacrificed at day 14, and colon and mesenteric lymph node (MLN) tissues were explanted to evaluate
the clinical severity of colitis. Colon length was measured as an indicator of colonic inflammation.
The colon/body weight indices were calculated as the ratio of the colon wet weight and the total
body weight (BW), and as the ratio of the colon length and the total BW of each mouse. Body weight,
occult and rectal bleeding and stool consistency were monitored daily. Disease activity index (DAI)
was determined by scoring changes in body weight, occult blood and gross bleeding.
2.4. DNA Extraction from Stool
Total genomic bacterial DNA was isolated from frozen stool samples of mice using
the QIAamp®Fast DNA Stool Mini Kit (QIAGEN, Hilden, Germany), according to the
manufacturer’s instructions.
2.5. Bacterial Microbiome Estimated by 16S rRNAs Metagenetics
16S metagenetic analyses were carried out at Genomix4life (spin-off of the University of Salerno,
Fisciano, Italy) by using the Illumina MiSeq platform. The V3-V4 region of the 16S rRNA gene
was amplified for analysis of diversity inside the domains of Bacteria [21]. PCR and sequencing
analyses were carried out according to the protocol of Genomix4life. Quality control (QC) and
taxonomic assignments were undertaken according to the QIIME and the Ribosomal Database Project
Bayesian classifier in combination with a set of custom designed informatics pipelines implemented
by Genomix4life for analyses of microbial communities. Taxonomic attribution was carried out using
the BLAST search in the NCBI 16S ribosomal RNA sequences database [22]. The percentage of each
bacterial OTU was analyzed individually for each sample, providing relative abundance information
among the samples based on the relative numbers of reads within each [23]. Alpha diversity (observed
species, Chao1 richness and Shannon diversity indices) was calculated using Qiime [24,25]. Differences
in microbial communities between mouse groups were also investigated using the phylogeny-based,
unweighted Unifrac distance metric [26].
2.6. Cytofluorimetric Analysis
FoxP3 staining: Mesenteric lymph nodes (MLNs) were isolated from mice fed with tomato
(Control or Bronze)-enriched food. MLNs were passed through a 30 m cell strainer (Miltenyi Biotec,
Bergisch Gladbach, Germany) to obtain a single cell suspension and then washed with DPBS (Gibco,
Waltham, MA, USA) + 0.5% bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, MO, USA).
Single cell suspensions were stained with CD4-FITC and CD25-PE (Miltenyi Biotec, Bergisch Gladbach,
Germany). Cells were then permeabilized with Foxp3 Fixation/Permeabilization Kit (eBioscience,
San Diego, CA, USA) and subsequently washed with PERM Buffer (eBioscience, San Diego, CA,
USA). Finally, cells were stained with Foxp3-APC (Miltenyi Biotec, Bergisch Gladbach, Germany),
according to the manufacturer’s instructions. Flow Cytometer acquisition was performed using
NAVIOS (Beckman Coulter, Brea, CA, USA).
T cell Intracellular Staining: T cells from MLNs of mice fed with tomato (Control or
Bronze)-enriched food were cultured with a 500X Cell Stimulation Cocktail (eBiosceince, San Diego,
CA, USA) for 12 h, washed with DPBS + 0.5% BSA and stained with CD4-APC-Vio700 (Miltenyi
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Biotec, Bergisch Gladbach, Germany). After washing, cells were then permeabilized with BD
CytoFix/CytoPerm®Fixation/Permeabilization Kit® (BD Biosciences, Franklin Lakes, NJ, USA),
washed with PERM Buffer, and stained with: IL-17A-FITC, TNF-PE and IFN-APC according to
manufacturer’s instructions (Miltenyi Biotec, Bergisch Gladbach, Germany). Flow Cytometer data
analysis was performed using NAVIOS (Beckman Coulter).
2.7. RNA Extraction and qPCR Analysis
Total RNA was isolated from the medial colon of WT and Winnie mice. The RNA was extracted
using TRIzol® (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s
instructions. Total RNA (1 g) was reverse transcribed using the iScript cDNA Synthesis kit (Biorad,
CA, USA) with random primers for cDNA synthesis. Gene expression of Tnf-, Ifn, Il-10, Hmox1,
Slpi and Gapdh was assessed using the TaqMan gene expression assay (Thermo Fisher Scientific,
MA, USA) murine probes: Mm00443258_m1, Mm01168134_m1, Mm00439614_m1, Mm00516005_m1,
Mm00441530_g1 and Mm99999915_g1, respectively. Real-time analysis was performed on a CFX96
System (Biorad, CA, USA) and for the relative expression the ∆∆Ct method was used.
2.8. Morphological Analysis
Tissue sections from the distal colon were fixed in 10% buffered formalin and embedded in
paraffin. Sections of 3 µm were stained using a hematoxylin eosin standard protocol. Images were
acquired using Leica LMD 6500 (Leica Microsystems, Wetzlar, Germany).
2.9. Statistical Analysis
All data were expressed as the means ± SEM. All results were obtained from three consecutive
and independent experiments.
Metagenomic data (Unifrac distance metric and taxonomic abundance) were analyzed by Principal
Component Analysis (PCA) [27,28] using a statistical software Statistica for Windows (Statistica 6.0
for Windows 1998, StatSoft, Vigonza, Italia). Samples more similar to each other should appear closer
together according to the respective axis reflecting the variation among all samples [29]. This technique
is useful for displaying clusters existing within data. The variables (features) reflect the relative
bacterial composition in a sample at a particular taxonomic level. In addition, Permut-MatrixEN
software was used to identify clusters at the level of the mouse groups and taxa [30].
Statistical analysis of the relative abundances of microbial genera was based on Duncan’s Multiple
Range test, with a significance level of P ≤ 0.05. Finally, unless specifically described, other data and
group differences were analyzed and compared by paired or unpaired, two-tailed Student’s t-tests.
Grouped analyses were performed with the two-way ANOVA test, using Bonferroni as a post test.
3. Results
3.1. Administration of a Bronze Tomato-Enriched Diet to the Murine Model of Ulcerative Colitis, Winnie
We recently demonstrated that the administration of a murine chow enriched with 1% of dried
Bronze tomato was able to prevent/delay the intestinal damage induced by DSS administration
using WT C57Bl/6 mice [19]. However, we did not determine whether the Bronze tomato dietary
supplement was able to exert beneficial effects in the context of an ongoing intestinal inflammation.
Here, we explored the effects of nutritional intervention in a model of spontaneous progressive
ulcerative colitis. WT and Winnie mice were fed for 2 weeks with 1% control (Control) or bronze
(Bronze) tomato-enriched diets. Figure 1A shows the experimental setup. Administration of the
enriched diets did not alter the weight of WT and Winnie mice (Figure 1B) nor their colon weight
and length (Figure 1C,D, respectively). Morphological analysis of the explanted colon did not reveal
differences between Control and Bronze treated mice (Figure S1).
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Figure 1. Experimental design and macroscopic characterization of the experimental groups. (A) 
Sex-matched mice were divided into four groups based on their genotype (Wild Type or Winnie) and 
their diet (enriched with Control or Bronze lyophilized tomato fruit). Mouse weight was recorded at 
the beginning of diet administration (Day 0) and at the end of the trial (2 Weeks). Fecal samples were 
collected for microbial meta-analyses at both time points (Day 0 and Week 2). Tissues were explanted 
and analyzed at the end of the treatments as indicated. Analysis of mice from different groups 
included: mouse weight (B), colon weight/mouse weight (C) and colon length/mouse weight (D). 
Black bars show the values at Day 0, striped bars show the Control- and white bars the 
Bronze-enriched diet. Statistical evaluation was performed using unpaired two-tailed Student’s 
t-tests. 
3.2. IL-17A Reduction in CD4+ Mesenteric Lymph Node (MLN) T Cells Treated with a Bronze Tomato Diet 
Following two weeks of tomato-enriched diets, we isolated and analyzed the intracellular 
cytokine production of the MLNs CD4+ T cells. The Bronze enriched diet resulted in a reduced 
percentage of CD25+Foxp3+ (Figure 2A) and increased percentage of TNFα+ cells (Figure 2B) 
compared to the Control diet. Both changes were not significantly different, but the trend was 
consistent independent of the genotype of the mice. A Bronze diet resulted in a significant reduction 
in the percentage of IL-17A CD4+ cells in WT mice and a similar trend in Winnie mice, while the 
percentage of IFNγ+CD4+ cells was unchanged (Figure 2C) both in WT and Winnie. Of note, the 
percentage of IFNγ+CD4- cells was reduced by the Bronze diet, particularly in Winnie mice (Figure 
2D). 
Figure 1. Experimental design and macroscopic characterization of the experimental groups.
(A) Sex-matched mic were divided into four groups b sed on their genotyp (Wild Type or Winnie)
and their diet (enriched with Control r Bronze lyophilized tomato fruit). Mouse weight was recorded
at t beginni g of diet adminis ati n (Day 0) and at th end of he trial (2 Weeks). Fecal samples w re
collected for microbial meta-analyses at both time points (Day 0 and Week 2). Tis ues were ex anted
and analyzed at the end of the treatments as indicated. A alysis of mice from different groups included:
mouse weight (B), colon weight/mouse weight (C) and colon length/mouse weight (D). Black bars
show th values at Day 0, striped bars show the Control- and white bars th Bronze-enriched diet.
Statistical evaluation was performed using unpaired two-tailed Student’s t-tests.
3.2. IL-17A Reduction in CD4+ Mesenteric Lymph Node (MLN) T Cells Treated with a Bronze Tomato Diet
Following two weeks of tomato-enriched diets, we isolated and analyzed the intracellular cytokine
production of the MLNs 4 T cells. The Bronze enriched diet resulted in a reduced percentage
of CD25+Foxp3+ (Figure 2A) and increased percentage of TNFα+ cells (Figure 2B) compared to the
Control diet. Both changes were not significantly different, but the trend was consistent independent
of the genotype of the mice. A Bronze diet resulted in a significant reduction in the percentage of
IL-17A CD4+ cells in WT mice and a similar trend in Winnie mice, while the percentage of IFNγ+CD4+
cells was unchanged (Figure 2C) both in WT and Winnie. Of note, the percentage of IFNγ+CD4− cells
was reduced by the Bronze diet, particularly in Winnie mice (Figure 2D).
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Figure 2. Mesenteric lymph node T cell cytokine staining. (A) Representative Treg staining of CD4+ 
cells. Histograms represent the percentages of Foxp3+CD25+ cells in the MLNs of mice fed with 
Control-enriched diet (striped bars) and Bronze-enriched diet (white bars). (B) Representative 
density plot analysis of intracellular staining of MLNs from Winnie mice. (C,D) Intracellular staining 
of IFNγ and IL-17A in the CD4+ (C) and CD4− (D) MLN cells of WT and Winnie mice after 2 weeks of 
Control or Bronze-enriched diets. Statistical evaluation was performed using unpaired two-tailed 
Student’s t-tests. * P < 0.05. 
3.3. Bronze Tomato Diet Molecular Signature 
We previously demonstrated that the administration of a Bronze enriched diet was able to 
reduce the expression of inflammatory cytokines (Il-6, Tnf-α, Il-1α, Il-1β, Il-12) in the colon of WT 
mice [19] and that the expression level of Slpi was a reliable marker for the oral intake of quercetin 
[31,32]. We next analyzed the expression levels of Tnf-α, Ifnγ, Il-10, Slpi and Hmox1 in the colon of 
WT and Winnie mice. While both a Bronze and Control enriched diet significantly increased Il-10 
expression in WT mice (Figure 3A), only a Bronze diet induced a higher increase in Il-10 in Winnie 
mice. Tnf-α and Ifnγ colon expression was generally lower in mice fed with Control or Bronze diets 
in both the Winnie and WT mice (Figure 3B,C). A significant reduction in Ifnγ expression was 
observed in Winnie mice fed with a Bronze diet compared to Day 0, but not in Winnie mice fed with 
a Control diet. Slpi, a major checkpoint for the anti-inflammatory activity of quercetin [31,32], was 
significantly induced by both the Control and the Bronze-enriched diets both in WT and Winnie 
mice (Figure 3D). Slpi induction was higher in Winnie compared to WT mice. Hmox1 expression 
was similar to that of Slpi, suggesting an anti-inflammatory pathway that is induced by the Bronze 
diet (Figure 3E).    
Figure 2. Mesenteric lymph node T cell cytokine staining. (A) Representative Treg staining of CD4+
cells. Histograms represent the percentages of Foxp3+CD25+ cells in the MLNs of mice fed with
Control-enriched diet (striped bars) and Bronze-enriched diet (white bars). (B) Representative density
plot analysis of intracellular staining of MLNs from Winnie mice. (C,D) Intracellular staining of IFNγ
and IL-17A in the CD4+ (C) and CD4− (D) MLN cells of WT and Winnie mice after 2 weeks of Control
or Bronze-enriched diets. Statistical evaluation was performed using unpaired two-tailed Student’s
t-tests. * P < 0.05.
3.3. Bronze Tomato Diet Molecular Signature
We previously demonstrated that the administration of a Bronze enriched diet was able to reduce
the expression of inflammatory cytokines (Il-6, Tnf-α, Il-1α, Il-1β, Il-12) in the colon of WT mice [19]
and that the expression level of Slpi was a reliable marker for the oral intake of quercetin [31,32].
We next analyzed the expression levels of Tnf-α, Ifnγ, Il-10, Slpi and Hmox1 in the colon of WT and
Winnie mice. While both a Bronze and Control enriched diet significantly increased Il-10 expression in
WT mice (Figure 3A), only a Bronze diet induced a higher increase in Il-10 in Winnie mice. Tnf-α and
Ifnγ colon expression was generally lower in mice fed with Control or Bronze diets in both the Winnie
and WT mice (Figure 3B,C). A significant reduction in Ifnγ expression was observed in Winnie mice
fed with a Bronze diet compared to Day 0, but not in Winnie mice fed with a Control diet. Slpi, a major
checkpoint for the anti-inflammatory activity of quercetin [31,32], was significantly induced by both
the Control and the Bronze-enriched diets both in WT and Winnie mice (Figure 3D). Slpi induction
was higher in Winnie compared to WT mice. Hmox1 expression was similar to that of Slpi, suggesting
an anti-inflammatory pathway that is induced by the Bronze diet (Figure 3E).
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Figure 3. Two weeks of Bronze-enriched diet induced Slpi and Hmox1 expression in the medial 
colon of WT and Winnie mice. Histograms represent the average expression of Il-10, Tnf-α, Ifnγ, Slpi 
and Hmox1 (A–E respectively) measured by real time PCR in the medial colon of WT and Winnie 
mice after two weeks of Control- (striped bars) and Bronze-enriched diet (white bars). Black bars 
represent the gene expression at Day 0. All bars represent mean expression ± SEM for each treatment. 
Control and Bronze dependent expression were compared to WT Day 0 for the statistical evaluation. 
Student’s t-test was used to compare every measurement to the corresponding WT Day 0 and 
evaluate the significance of the data. ** P < 0.01,* P < 0.05 (Student’s t-test). Grouped analyses were 
performed with the two-way ANOVA test, using Bonferroni as a post test. 
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mice (2.413 and 2.180, respectively, P = 0.011). No statistically significant differences were found for 
the number OTUs and Chao index (Supplemental Material Table S1). To investigate the response of 
the microbiota to the host intake of different dietary regimes, fecal material was collected from mice 
following two weeks of Bronze or Control enriched chow. After two weeks of feeding Control 
tomato, the WT mice increased their OTUs and their Shannon index compared to Day 0. Compared 
to the Control tomato diet, all WT and Winnie mice showed non-significant reductions in OTUs on 
the Bronze tomato diet. In our previous studies, the diversity and richness of the microbiota of mice 
did not show significant differences (P > 0.05) in response to different diets [19]. The 3 
phylogeny-based β-diversity analyses did not show statistical separation between the composition 
the microbiome of fecal mouse samples after two weeks of Bronze or Control tomato diets (Figure 
S2). Samples were mainly clustered according to the genotype (WT or Winnie mice).  
The evaluation of the 16S revealed a significant difference (P < 0.05) between 20-week old WT 
and Winnie mice. In particular, the relative abundance of Bacteroidetes and Firmicutes (41.97% and 
39.26% in WT vs. 60.62% and 23.36% in Winnie mice), as well as the ratio between them (1.14 vs. 2.76 
respectively, P = 0.022) confirmed differences already known for hosts characterized by ongoing 
intestinal inflammation [33–36]. Two weeks of dietary intervention changed the microbial content of 
both WT and Winnie mice. The differences in bacterial abundance monitored by 16S segregation, 
observed at time zero, were later lost as fecal material from WT and Winnie mice could not be clearly 
differentiated (Figure 4).  
We aimed to identify bacterial genera susceptible to the polyphenol-enriched diet. We 
compared Control and Bronze-fed groups independently of genotype (Figure 5). Data revealed that 
two weeks of Bronze diet resulted in an increase of Flavobacterium and a reduction in the relative 
Fig re 3. Two weeks of Bronze-enriched diet induced Slpi and Hmox1 expression in the medial colon
of WT and Winnie mice. Histograms represent the average expression of Il-10, Tnf-α, Ifnγ, Slpi and
Hmox1 (A–E respectively) measured by real time PCR in the medial colon of WT and Winnie mice after
two weeks of Control- (striped bars) and Bronze-enriched diet (white bars). Black bars represent the
gene expression at Day 0. All bars represent mean expression ± SEM for each treatment. Control and
Bronze dependent expression were compared to WT Day 0 for the statistical evaluation. Student’s t-test
was used to compare every measurement to the corresponding WT Day 0 and evaluate the significance
of the data. ** P < 0.01,* P < 0.05 (Student’s t-test). Grouped analyses were performed with the two-way
ANOVA test, using Bonferroni as a post test.
3.4. Dysbiotic Intestinal Microbiota Communities Changed Following Two Weeks on a Bronze Tomato Diet in
Winnie Mice
Time zero for each mouse was collected both for WT and Winnie mice. At day 0 for the mice
fed with Control tomato-enriched diet, the Shannon index of the Winnie mice was higher than the
WT mice (2.413 and 2.180, respectively, P = 0.011). No statistically significant differences were found
for the number OTUs and Chao index (Supplemental Material Table S1). To investigate the response
of the microbiota to the host intake of different dietary regimes, fecal material was collected from
mice following two weeks of Bronze or Control enriched chow. After two weeks of feeding Control
tomato, the WT mice increased their OTUs and their Shannon index compared to Day 0. Compared to
the Control tomato diet, all WT and Winnie mice showed non-significant reductions in OTUs on the
Bronze tomato diet. In our previous studies, the diversity and richness of the microbiota of mice did
not show significant differences (P > 0.05) in response to different diets [19]. The 3 phylogeny-based
β-diversity analyses did not show statistical separation between the composition the microbiome of
fecal mouse samples after two weeks of Bronze or Control tomato diets (Figure S2). Samples were
mainly clustered according to the genotype (WT or Winnie mice).
The evaluation of the 16S revealed a significant difference (P < 0.05) between 20-week old WT
and Winnie mice. In particular, the relative abundance of Bacteroidetes and Firmicutes (41.97% and
39.26% in WT vs. 60.62% and 23.36% in Winnie mice), as well as the ratio between them (1.14 vs.
2.76 respectively, P = 0.022) confirmed differences already known for hosts characterized by ongoing
intestinal inflammation [33–36]. Two weeks of dietary intervention changed the microbial content
of both WT and Winnie mice. The differences in bacterial abundance monitored by 16S segregation,
observed at time zero, were later lost as fecal material from WT and Winnie mice could not be clearly
differentiated (Figure 4).
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Figure 4. Total bacteria found in feces of WT and Winnie mice. Relative abundance (%) of total
(16S rRNA) bacteria, found at the phylum level in the fecal samples of WT and Winnie mice at Day 0
(0W) and after two weeks (2W) on Bronze (Bronze) or Control tomato (Control) diets.
We aimed to identify bacterial genera susceptible to the polyphenol-enriched diet. We compared
Control and Bronze-fed groups independently of genotype (Figure 5). Data revealed that two weeks
of Bronze diet resulted in an increase of Flavobacterium and a reduction in the relative abundance
of Oscillospira. When considering mice in relation to their different genotypes, the relative increase
in specific bacterial content was directly related with permissive diet. Genotype-specific differences
appeared as a direct consequence of the starting concentration of specific bacteria before the dietary
intervention. Particularly, with the Bronze diet we detected a significant increase in Lactobacillus
and Parabacteroides in WT mice. The same trend was observed for Parabacteroides, but did not reach
significance in Winnie mice, which were characterized by an increase in Odoribacter. An opposite
trend was observed for Desulfovibrio and Natronincola that decreased in WT mice following Bronze diet
administration, while Akkermansia and Blautia decreased significantly in Winnie mice.
At the species level, WT mice showed a different profile compared to Winnie mice (Supplementary
Material Figure S3). The Bronze-enriched diet was able to drive the changes in bacterial species in both
WT and Winnie mice. Data revealed that two weeks of Bronze diet resulted in an increase of the relative
amount of Akkermansia muciniphila in both WT and Winnie mice compared to the Control tomato diet
(Supplementary Material Figure S3). In contrast, the Bronze- enriched diet drove a reduction in the
relative content of Bacteroides species (B. chinchilla, B. rodentium, B. xylanisolvens), Escherichia albertii,
Parabacteroides distasonis and Ruminococcus gnavus in both WT and Winnie mice.
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4. Discussion
IBD includes Crohn’s disease (CD) and ulcerative colitis (UC), with idiopathic chronic
inflammation of the intestine often occurring at a young age. Treatment of IBD has changed since the
introduction of monoclonal antibodies blocking the inflammatory cytokine TNFα have augmented
traditional treatments, such as corticosteroids and thiopurines. Alternative biological intervention is
extremely useful in case of early-stage treatment of patients with IBD forms resistant to conventional
therapy [37–39]. Together with the introduction of numerous new therapeutic strategies, the assessment
of the status of IBD activity is being addressed. Terms like “mucosal healing”, “biochemical remission”
and “deep remission” are now commonly used to discriminate between different degrees of response
to the therapeutic intervention of patients [40]. Mucosal healing is an endoscopic assessment of
the absence of inflammation, nonetheless, it is possible to have mucosal healing in patients with
elevated fecal levels of calprotectin indicating an ongoing process of neutrophil infiltration. It is not
surprising that mucosal healing is not a good predictor of the desired sustained clinical remission [41].
Furthermore, dysbiosis has been reported in IBD patients, even in the absence of inflammation [42],
suggesting that unless corrected, the dysbiosis may play a role in disease recurrence. Finally,
the reduced diversity in the microbiota of UC patients [43] has a negative influence on the production
of metabolites, such as butyrate, that sustain intestinal epithelium integrity [44]. Indeed, butyrate
producing bacteria are scarcely represented in the microbiota of UC patients [43], suggesting that
intervention to correct dysbiosis should be provided before dietary supplementation that support
butyrate production (such as soluble fibers).
We recently described the effects of a diet supplemented with a tomato line enriched in different
polyphenols [19] as an innovative tool to evaluate beneficial effects of plant bioactive compounds on
the disease activity index in a mouse model of IBD. We also demonstrated that the administration of a
murine chow enriched with 1% of Bronze tomato fruit was able to affect numerous biological features
of the intestinal immune response in WT mice. Furthermore, we also showed that two weeks of the
Bronze nutritional regime profoundly changed the composition of the intestinal microbiota of WT mice
compared with the administration of diets enriched with near isogenic tomato lines [19]. This present
study aimed to identify whether a Bronze diet could exert beneficial effects during inflammation.
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In order to address this, the mouse model Winnie was used as its phenotype resembles the progressive
intestinal inflammation observed in human UC.
Two weeks of nutritional intervention with Bronze-enriched diet was not able to correct
the macroscopic features observed in 20-week old Winnie mice, which included weight loss,
colon shortening and loss of stool consistency. Surprisingly, at the intracellular level, it was possible
to detect a decrease in the percentage of cells positive for CD4+IL17A and CD4−IFNγ in the MLNs.
Analysis of gene expression in the colonic tissue revealed a significant induction of Slpi both in Winnie
and WT mice, confirming previous observations of bone marrow derived dendritic cells exposed to
quercetin [31,32]. Slpi is a potent NF-kB inhibitor, its expression and secretion are able to suppress
inflammation and facilitate tissue repair. Accordingly, the Bronze-enriched diet was able to induce the
expression of Hmox1, another potent anti-inflammatory protein recently recognized as an important
checkpoint for intestinal inflammation [45]. Both tomato-enriched diets induced Il-10 expression in
colonic tissues, but the Bronze-enriched diet was still able to further promote Il-10 expression compared
to Control tomato diet in the UC model Winnie. The Bronze-enriched diet was able to reduce Ifnγ
and Tnf-α in both WT and Winnie mice, although a significant reduction was evident only for Ifnγ in
Winnie mice. Similar trends were observed for Control tomato-enriched diets, although the reductions
in expression did not reach significance suggesting that the polyphenol-enriched component of the
Bronze tomatoes was, at least partially, involved in reduction of Ifnγ and Tnf-α expression. These data
were in line with the observations in MLNs.
The potential of nutritional intervention, enriched with bioactives, to modulate an already
established intestinal inflammation has implications for the development of future treatments for IBD.
The intestinal microbiota and its dysbiosis are thought to play a fundamental role in either the cause,
persistence or recurrence of IBD [46,47].
Strikingly, the Winnie mice were characterized by differences in their intestinal microbial
content compared to WT mice (Supplementary Material Figure S3). The administration of the
Bronze-enriched diet was also able to reshape the microbial community of both genotypes, WT and
Winnie. We recently explored the possibility that some polyphenols, including quercetin in particular,
work as an iron-chelating agent [48]. When nutritional regimes enriched in quercetin, such as the
Bronze diet, are introduced into the diet, iron sequestration may create challenging conditions in
the intestinal lumen. This mechanism is equally true for homeostatic and inflammatory conditions,
thus the final results may partially overlap. Some microbial species may be able to resist iron starvation
better, while others may proliferate less and become underrepresented. In the present study we
obtained some results showing genotype-independent trends for decreases in Oscillospira and increases
in Flavobacterium even though of different magnitudes. On a genera level, differences in the responses of
communities to the Bronze diet were less consistent between WT and Winnie mice. This result could be
related to the number of bacteria represented at the beginning of the dietary intervention, where species
underrepresented at time zero, will likely fail to receive benefits from the polyphenol-enriched diet
compared to the predominant microbiota present at the beginning of the intervention.
5. Conclusions
The results from the present study will be important for understanding the effects of nutritional
intervention as an adjuvant in the treatment of IBD [49–52].
Nutritional regimes fortified in bioactive compounds may help to correct intestinal dysbiosis,
prevent recurrence and support complete remission of IBD. More studies will be required to design the
most effective strategies to be used, particularly for patients affected by intestinal dysbiosis. The diet
may create favorable conditions for healthy bacterial growth, but may prove ineffective in the absence
of concomitant probiotic administration. Furthermore, using different experimental strategies, it will be
crucial to assess efficiency and safety of a prolonged administration to a Bronze-enriched dietary regime.
Will the microbiota community become stable and the inflammatory response been suppressed?
Is the microbiota community Bronze-dependent and the dietary intervention be suppressed once
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stabilized? We still largely ignore numerous aspects of the axis between nutrition–inflammation
and microbiota selection. With the present results, we pave the way for future studies focused on
bioactive- enriched food acting as adjuvants for IBD patients in deep remission from dysbiosis to
prevent disease recurrence.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/10/12/1862/
s1, Figure S1: Histological characterization of the experimental groups. Figure S2: Principal component analysis
(PCA) of total bacterial genera found in feces of mice. Figure S3: A Bronze-enriched diet affected the fecal bacterial
species of WT and Winnie mice. Table S1: Number of identified species (OTUs), Shannon diversity index and
Chao 1 mean of the microbiota of C57BL/6 (WT) and Winnie mice fed with Control tomato or Bronze tomato
supplemented chow (Bronze). Values within a column with different superscript letters are significantly different
(P < 0.05; FDR < 0.05).
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